Xofigo (Radium 223) is a medication that we deliver in the office for men with metastatic prostate cancer that has become resistant to testosterone lowering medications ("castration-resistant") who have painful bone metastases. This therapy is well-tolerated and extends survival by 3-7 months, reduces bone pain and the risk of developing a bone fracture. Watch this short video to see how it's done.
Dr. Lawenda Discusses Xofigo (Radium-223) for Metastatic Castration Resistant Prostate Cancer
Xofigo (Radium 223) is a medication that we deliver in the office for men with metastatic prostate cancer that has become resistant to testosterone lowering medications ("castration-resistant") who have painful bone metastases. This therapy is well-tolerated and extends survival by 3-7 months, reduces bone pain and the risk of developing a bone fracture. Watch this short video to see how it's done.
![Jean-Féry Rebel - Les élémens|The Elements (1737) [w| score]](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vukN6G1YRKuEwNMazpaF4imULVKN9BUaTzvo1camHgb2ZFn0W-e7of4i0rvgBB_CTVdr4MVcmJpCDtmKv2WFnHtSpda87Oht58yQ8fZHqP1riVvQ=w680)
0 Comments